Our novel data demonstrates that ABs plus PDE5-Is was the best combination for treatment for LUTS/BPH in terms of improving outcomes of IPSS total score, IPSS storage subscore and IPSS voiding subscore. This evidence concerns the gene PDE5A and benign prostatic hyperplasia.